CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback